Boehringer, Perosphere square off for first bloodclot treatment approval

Two pharmaceutical companies in Danbury ' one big and one small ' are in a race to get federal approval for drugs that can reverse the effects of blood clotting agents. Both Boehringer Ingelheim, a international company with billions at their disposal, and local start up Perosphere, are in trials with drugs that can reserve the effects of certain anticoagulants, also known as blood thinners.



via Danbury Newswire http://ift.tt/1w0GfJK